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Effect of Postoperative Diclofenac on
Anastomotic Strength and Histologic Healing
in Rabbit Small Intestine
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In this experimental study, we investigated the effects of a 5-day postoperative treatment
with the nonsteroidal anti-inflammatory drug (NSAID) diclofenac on anastomotic
healing in rabbits. NSAIDs are widely used analgesics in today’s ‘‘fast-track surgery,’’
raising concerns about their potential negative effects on healing in humans. A total of 33
New Zealand White female rabbits underwent laparotomy and 2 separate end-to-end
anastomoses of the ileum.. The animals were randomized to receive subcutaneous
diclofenac 4 mg/kg/d (17 experimental rabbits) or subcutaneous isotonic saline 0.1 mL/kg/
d (16 control rabbits) postoperatively. On the fifth postoperative day, the animals were
humanely killed, and anastomotic leakage, anastomotic breaking strength, and
histopathologic changes were evaluated. Breaking strength in the diclofenac group
was 21% lower than in the placebo group (P¼0.027). Anastomotic leakage was found in 4
rabbits in the diclofenac group (26.7%). The rabbits treated with diclofenac demonstrated
a 16% lower collagen deposition compared with the placebo group (P ¼ 0.008). In our
study, postoperative treatment with diclofenac had a negative effect on the anastomotic
healing and strength in the ileum of rabbits. Caution should be taken in the use of
diclofenac after gastrointestinal surgery.
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Anastomotic leakage is a severe complicationafter intestinal surgery, with an occurrence of
1% to 3% after small intestine resection, 3% to 4%
after colonic resection, and 10% after rectal resection
with an associated mortality of up to 40%.1–4 It also
leads to increased morbidity caused by abscess
formation, peritonitis, ileus, and sepsis, which can
result in prolonged hospitalization and increased
cost.5 Common risk factors include smoking, alcohol
abuse,6 American Society of Anesthesiologists score
over 3, malnutrition,7 cardiovascular disease,8 male
sex,9 and technical errors.
Healing of the intestinal wall is an organized and
complex process that initially involves inflammatory
mediated enzymes such as cyclooxygenases (COX-1
and COX-2). Inhibition of COX-2 is suspected to
interfere with normal wound healing in the epithelial
tissue of the gastrointestinal tract.10 The collagen
concentration fluctuates during the healing process,
showing an initial decrease owing to collagenase
activity during the inflammatory phase, and then an
increase during the proliferation phase.11,12
Nonsteroidal anti-inflammatory drugs (NSAIDs)
are an important component in today’s fast-track
treatment of postoperative pain and can reduce the
need for opioids by approximately 30%. In the present
experiment, we chose to study diclofenac, an NSAID
with a fourfold higher selectivity for COX-2 compared
with COX-1 (IC80: 0.23 mM versus 1.0 mM). However,
at the relevant therapeutic level, 70% of COX-1 would
also be inhibited.13 Retrospective studies focusing on
NSAIDs with a predominant inhibition of COX-2
indicate a clear trend toward increased anastomotic
leakage after postoperative pain treatment.14–16 Ani-
mal studies show more inconclusive results, perhaps
because most were performed on rats, which have a
significantly different immune response from hu-
mans.17–19 Previous studies show that diclofenac
decreases collagen concentration, but there are con-
flicting results regarding the correlation between
anastomotic breaking strength and peri-anastomotic
collagen concentration.17,20–22
The aim of this experimental study was to
investigate whether diclofenac inhibits the anasto-
motic healing process as assessed by increased




A total of 33 New Zealand White female rabbits
with a mean weight of 2.85 kg (range, 2.25–3.58 kg)
were included. They were kept in wire cages at
room temperature (18C8 to 20C8), with 40% to 60%
humidity, and a 12-hour light/dark cycle. The cages
included wood shavings and hay. The animals had
access to water and were fed a standard laboratory
diet, Altromin 2120 (Brogaarden, Gentofte, Den-
mark), once daily. The rabbits were acclimatized for
1 week before the procedure.
This project was approved by the Danish Na-
tional Experimental Animal Inspectorate (J.nr.: 2012-
15-2934-00664; influence of drugs on intestinal
anastomosis).
Study design
From previous studies in our group, the mean value
of the minimal tensile strength (MITS) on small
intestinal anastomoses in the rabbit was found to be
1.89 N with an SD of 0.36 N. A difference of 30%
between the 2 groups was considered clinically
relevant. With a 1:1 randomization, a significance
level of 5%, and a power of 80%, the number needed
in the study was calculated to be 32 animals (Stata/
IC, Version 12.0, StataCorp, College Station, Texas).
The animals were randomized 1:1 (available in
the public domain at https://www.random.org)
into an experimental group of 17 rabbits receiving
subcutaneous diclofenac 2 mg/kg (Voltaren, 25 mg/
mL, Novartis, Copenhagen, Denmark) twice a day
(bid) until the fifth postoperative day (POD5) and a
control group of 16 rabbits receiving subcutaneous
isotonic saline 0.05 mL/kg bid. The rabbits were
humanely killed on POD5.
Surgical procedure
The rabbits were not fasted before the procedure as
they are physically almost incapable of regurgita-
tion. The animals were sedated by subcutaneous
injection with a combination of fentanyl and
fluanisone 0.3 mL/kg (Hypnorm, 10 mg/mL,
Vetapharma Ltd, Leeds, UK) and midazolam 2
mg/kg (Dormicum, 5 mg/mL, Roche, Basel, Swit-
zerland). The rabbits were then intubated with an
endotracheal tube, size 2.5 to 3.5 mm (Ru¨sch,
Kernen, Germany), and if needed, an extra dose of
propofol 2 to 5 mg (Propvet, 10 mg/mL, Abbot
Laboratories Ltd, Queenborough, UK) was given
intravenously. Anaesthesia was maintained with 2%
sevoflurane (Sevofluran ‘‘Baxter,’’ Baxter A/S, Aller-
ød, Denmark) via an MCM 801 ventilator (Dameca,
Rødovre, Denmark). Perioperative analgesia con-
sisted of intravenous fentanyl 1 mL/h (Haldid, 50
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lg/mL, Jansen-Cilag, Beerse, Belgium). Hypother-
mia was prevented by placing the rabbits on a
heating pad set to 418C. To prevent dehydration, 10
mL isotonic saline was administrated subcutane-
ously before surgery. A pulse-oximeter (Nonin
8500V, Nonin Medical, Plymouth, Minnesota) was
used to monitor saturation and heart rate during
surgery.
A 4-cm midline laparotomy was performed under
aseptic conditions after shaving the abdomen. At
approximately 20 cm and 40 cm, respectively,
proximal to the ileocecal junction, the small intestine
was severed and 2 separate end-to-end anastomoses
were made. The anastomoses were completed with
14 to 18 interrupted inverted single-layer 5-0 non-
resorbable sutures (Ethilon 4-0, Johnson & Johnson
Nordic, Birkerød, Denmark). The musculofascial
layer was closed with 3-0 resorbable sutures (Vicrylt
3-0, Johnson & Johnson Nordic) and the skin with 4-0
nonresorbable sutures (Ethilon 4-0, Johnson & John-
son Nordic). A combination of sulfadoxine and
trimethoprim 0.2 mL/kg (Duoprim Vet, Intervet
Danmark A/S, Ballerup, Denmark), a broad spec-
trum antibiotic registered for treatment of gastroin-
testinal infections in animals was given intravenously
as prophylaxis against infection at the end of the
surgery. Postoperative subcutaneous buprenorphine
(Temgesic, Schering-Plough Europe, Brussels, Bel-
gium) 0.05 mg/kg was administrated every 8 hours
for 3 days as pain treatment to the placebo group.
The animals’ food, water intake, and production of
stools were registered daily. Immediate indication to
kill the animals was weight loss .20% of preoper-
ative body weight or any clinical sign of acute ileus
(i.e., a combination of inactivity, large pupils, and
absence of food intake). The animals were humanely
killed with an overdose of 2 mL intravenous
Pentobarbital (Pentobarbital, 200 mg/mL: KU Life,
Copenhagen, Denmark). A repeat laparotomy was
performed, and the 2 anastomoses were inspected for
macroscopic leakage or infection. The 2 segments
were harvested by cutting 5 cm proximally and 5 cm
distally to the anastomoses, carefully removed
adhesions, and leaving the sutures in situ. The 10-
cm-long segments were cleansed with saline.
Anastomotic breaking strength
The breaking strength was tested on the distal
segment directly after harvesting using a tensile
machine (LF Plus; Lloyds Instruments, Fareham,
UK) equipped with XLC 10 N load cell (Lloyds
Instruments). We mounted the segment with 10 mm
between the anastomosis and the clamps on each side
and measured the minimal force (N) at breaking point
with a deformation rate of 10 mm/min. A software
program (Nexygen, Lloyds Instruments) was used to
calculate a load-strain curve, which showed the MITS
that ruptured the anastomosis. The rupture site was
classified as being either in the anastomotic line or
outside the anastomotic line.
Histopathologic analysis
After removal of the sutures, the proximal anasto-
motic segment was fixed in 4% formaldehyde. The
segment was dehydrated and embedded in paraffin
blocks and sliced 3-lm thin. To evaluate inflamma-
tory cell composition, a hematoxylin and eosin
(H&E) staining was performed. Masson’s trichrome
stain was used to assess collagen formation. A
conventional binocular Leica DMR light microscope
(Leica Microsystems A/S, Herlev, Denmark) with
objective 40/0.75 was used.
An experienced pathologist, who was blinded to
the randomization, graded the histologic changes of
the specimens. All specimens were evaluated twice to
ensure the quality of the assessment. The histologic
features were inflammatory cell infiltrate, fibroblast
deposition, collagen formation, blood vessel growth,
foreign body giant cells, and necrosis. Except from
foreign body giant cells and necrosis, the features
were scored from 1 to 4 (1 ¼ absent or minimally
present, 2¼mildly present, 3¼moderately present, 4
¼ markedly present). Foreign body giant cells and
necrosis were scored as present or absent.
Statistical analysis
The potential difference in MITS between the 2
groups and the effect of number of sutures, collagen,
and weight loss were assessed by a linear regression
analysis using a significance level of 0.05. The model
was checked by inspection of the residuals and gave
no cause for concerns. To compare the histologic
changes, the 2-tailed Fisher exact test was used. The
Student t test with unequal variances was used to
compare the weight loss between the groups. Data
were analyzed using Stata/IC (Version 12.0, Stata-
Corp). A P value , 0.05 was considered statistically
significant.
Results
Of the 33 animals, 3 died postoperatively. One rabbit
in the diclofenac group was humanely killed at
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POD1 after the discovery of strangulation and
necrosis of an intestinal segment due to its entrap-
ment in the abdominal wall, which was caused by
the failing of the suture line in the abdominal wall.
Two rabbits were found dead in their cages, 1 in the
diclofenac group at POD1 and 1 in the placebo
group at POD2; autopsy did not reveal cause of
death, and there was no sign of anastomotic leakage
or infection.
Four rabbits (26.7%) in the diclofenac group had
encapsulated feces close to the suture line at POD5
(Fig. 1). The anastomoses were considered as
dehisced and therefore not amenable to the MITS
test. No rabbits in the placebo group had any signs
of anastomotic leakage or infection. Both groups had
varying amounts of adhesions, and some animals
had partial intestinal occlusions without any overt
clinical symptoms.
Anastomotic breaking strength
The diclofenac group had a 21% lower breaking
strength (P¼ 0.027) in the MITS test compared with
the placebo group (Fig. 2, Table 1). Four rabbits, all
belonging to the diclofenac group, were not amena-
ble to the MITS test because of dehiscence. If this
condition is related to the diclofenac group, the
estimated difference in breaking strength is likely to
be conservative. There was no significant correlation
between the anastomotic breaking strength and
collagen formation (P¼0.11). Two ruptures occurred
outside the suture line in the diclofenac group and
one in the placebo group.
Histopathologic analysis
Histologic investigation of the anastomosis demon-
strated a lower collagen deposition in the treatment
group by 16.7% (P ¼ 0.008) compared with the
placebo group (Table 2, Figs. 3 and 4). Infiltration of
inflammatory cells was 16.6% (P¼ 0.26) lower in the
diclofenac group but the difference was not statis-
tically significant. No significant differences were
found in neovascularization, fibroblast deposition,
necrosis, or foreign body giant cells.
Both groups had similar postoperative status
regarding food and water intake, mobility, and
weight, where the mean weight loss was 5.2% for
Fig. 1 Encapsulated leakage at POD5 when a part of the
adhesion is removed.
Fig. 2 Box-whisker plots for the MITS values at POD5 by group.
Mean and median values are indicated by filled circles and bold
lines, respectively. Plot for the diclofenac group is based on the 11
non-dehisced rabbits.
Table 1 MITS and weight
Diclofenac (n ¼ 15)a Placebo (n ¼ 15)a P value
MITS (N) 1.39 (0.70–2.03)b 1.76 (1.30–2.58) 0.027
Preoperative weight (kg) 2.92 (2.25–3.38) 2.79 (2.25–3.58) 0.39
Weight at POD5 (kg) 2.76 (2.14–3.23) 2.61 (2.15–3.38) 0.28
Weight difference,
preoperative–POD5 (kg) 0.15 (0.35 to 0.02) 0.18 (0.32 to 0.06) 0.44
aValues are presented as mean (range).
bBased on the 11 non-dehisced rabbits.
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the diclofenac group and 6.3% for the placebo group
(Table 1). There was no significant effect of the
number of sutures upon MITS.
Discussion
Using a rabbit ileum anastomosis model, we have
demonstrated that diclofenac has a negative effect
on anastomotic healing, resulting in a significant
lower breaking strength in the treatment group at
POD5 compared with the placebo group. Further-
more, the estimated difference is likely conservative
as 4 rabbits in the diclofenac group had dehisced
and would probably have shown low breaking
strengths if they could have been measured. The
reason for testing small intestine anastomosis was
the possibility of obtaining a high degree of
standardization compared with colonic anastomo-
sis, which is difficult or even impossible to handle in
most animals including the rabbit. Furthermore, the
healing process should be similar in the 2 organs.
The results from our study are similar to previous
studies investigating anastomotic strength in rats
and rabbits at POD7.17,21 From human studies, early
and late leaks may occur. The early leaks are more
frequent and occur typically at POD4 or 5 at a time
when the healing process shifts from the inflamma-
tory reaction to the proliferative phase,23 when the
strength of the anastomosis is lowest, and it is
therefore the most interesting time to investigate.
Although leakage often is diagnosed or recognized
at POD7 in humans, it is well known that a
diagnostic delay of 1 to 4 days is common. At
POD5, the fibroblast activity is at its highest level
with the collagen-rich granulation tissue leading to
increased strength in the anastomosis. During the









1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 Yes No Yes No
Diclofenac (n ¼ 15) 5 6 2 2 1 3 5 6 1 6 8 0 8 3 3 1 5 10 6 9
Mean 6 SD 2.1 6 1.0 3.1 6 1.0 2.5 6 0.6 1.8 6 1.0
Placebo (n ¼ 15) 10 4 1 0 0 1 6 8 0 5 3 7 10 4 1 0 2 13 7 8
Mean 6 SD 1.4 6 0.6 3.5 6 0.6 3.1 6 0.9 1.4 6 0.6
P value 0.26 0.61 0.008b 0.66 1.00 0.39
aHistologic features were rated 1 to 4, apart from necrosis and foreign body giant cells. Fisher exact test was used for testing the
statistically significant difference between the 2 groups.
bStatistically significant.
Fig. 3 Masson’s trichrome stained section displaying
granulation tissue close to the anastomosis for evaluation of
collagen formation. Example from the placebo group with a richer
collagen formation (blue) and less inflammatory cell infiltrate.
Fig. 4 Masson’s trichrome stained section displaying
granulation tissue close to the anastomosis for evaluation of
collagen formation. Example from the diclofenac group with less
collagen formation and more inflammatory cell infiltrate.
EFFECT OF DICLOFENAC ON ANASTOMOTIC HEALING IN RABBITS LE
Int Surg 2015;100 1439
proliferation phase, COX-2 expression has been
demonstrated to be associated with the mitogenic
activity for fibroblast and its production of collagen
through basic fibroblast growth factor (bFGF).24
Our results also demonstrate a tendency toward
an increased rate of anastomotic leakage in the
treatment group. The typical presentation was a
small amount feces in direct connection to the suture
line and encapsulated by fibrin without signs of
peritonitis, pointing toward an early leakage. The
subclinical leakage could later have led to compli-
cations if the animals had not been humanely killed
at POD5. Whether a possible negative effect of
NSAIDs is most likely to be manifest during the
early acute inflammatory phase or the later prolif-
erative phase is an important question. A recent
study concluded that the COX-2 selective NSAID
carprofen (no longer on the market for humans)
interferes at an early stage in the healing of ileum
anastomosis in rats, which showed a marked decline
in leakage rate if the treatment was delayed by 48
hours.25 This finding emphasizes the importance of
the early effects of NSAIDs in the anastomotic
healing process. A previous study also demonstrat-
ed a significant reduction of COX-2 enzyme con-
centration in peri-anastomotic tissue after 3 days of
postoperative treatment with diclofenac in rats but
did not find a reduction in anastomotic breaking
strength.18
In the evaluation of anastomotic healing, both
bursting pressure and breaking strength are com-
monly accepted methods. Measuring bursting
pressure during the proliferation stage often results
in rupture outside the anastomosis.20,21 According
to Ikeuchi et al, who investigated the 2 methods,
breaking strength was recommended from POD5
or later because of its greater accuracy to estimate
anastomotic healing.26 Although we chose break-
ing strength as the most suitable test, there were
some difficulties in preparation and mounting of
the segments as a result of adhesions and torsion in
or close to the anastomosis. This may have had
impact on our results, but we assume they are
equal for both groups. The use of nonresorbable
sutures is a major difference from the normal
surgical procedure in humans, where resorbable
materials are used. However, it is standard to use
nonresorbable sutures in experimental studies on
tensile strength of intestinal anastomosis to avoid
confounding factors such as degradation of suture
materials, which may differ among the individual
animals.
Hydroxyproline concentration in the peri-anas-
tomotic tissue is often used to measure the amount
of collagen. Most studies have not found any
correlation between anastomotic strength and
hydroxyproline concentration.20,21,27 It should be
noted that the measure of hydroxyproline concen-
tration in the peri-anastomotic tissue only informs
about the total amount of collagen and not
necessarily about new collagen production or the
quality of cross-linking, organization, and maturi-
ty.28 Recently, it was demonstrated that postoper-
ative diclofenac treatment significantly decreased
the accumulation of collagen in subcutaneous
granulation tissue.22 In the present study, we
therefore decided to histologically estimate the
new production of collagen in the granulation
tissue of the anastomosis and found decreased
collagen deposition in the treatment group but no
correlation with the anastomotic breaking
strength. Further histologic evaluation showed a
tendency toward increased infiltration of inflam-
matory cells in the treatment group, without any
difference in fibroblast infiltration, vascular
growth, foreign body giant cells, or necrosis
compared with the placebo group. As earlier
studies have suggested that COX-2–selective
NSAIDs inhibit the production of prostaglandin
E2,29 we did expect less infiltration of inflamma-
tory cells in the treatment group. The findings may
point toward a delayed rather than a decreased
inflammatory response and therefore to a delayed
healing process—a possible explanation that cor-
relates with findings on bone fracture healing in
rats treated with diclofenac.30
We were unable to find in the literature a
recommended dose of diclofenac for rabbits, and
there are no studies on the pharmacokinetics of
diclofenac in rabbits either in our or other studies to
our knowledge. The given dosage of 4 mg/kg/d has
been used in previous studies performed on rats17,18
and was therefore considered suitable in the present
study. This dosage is approximately twice as high as
recommended for humans but is still under toxic
levels.31 A higher dosage than normally adminis-
tered was used to study the possible existence of
adverse effects. The unknown serum concentration
of diclofenac in this study could be a confounder,
and ideally the serum concentration of diclofenac
should have been measured, but we had no access
to this.
Our results show that postoperative treatment
with diclofenac has a negative effect on anasto-
motic healing in the ileum of rabbits at POD5,
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indicated by reduced breaking strength and a
tendency toward increased anastomotic leakage.
As in any experimental study on animals, our
results cannot be directly extrapolated to humans
for various reasons. The study animals may be
more sensible to the given surgical intervention
with a different healing and recovery process. In
the present study model, 2 separate small intestinal
anastomoses were performed, which is different
from the clinical situation in which only 1 anasto-
mosis is the most common. With these reservations
in mind, our group recommends that diclofenac
and other NSAIDs with predominant inhibition of
COX-2 should be used with caution as analgesic
treatment after gastrointestinal surgery. A human
randomized controlled trial would be useful to
evaluate the risk of postoperative use of NSAIDs
after gastrointestinal surgery but could be difficult
to implement because of ethical considerations.
Future experimental studies should focus on
identifying which biological mechanisms NSAIDs
interfere with, the differences between the various
types of NSAIDs, and the timing of their interac-
tion.
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